Large Artery Stiffness: A Companion to the 2015 AHA Science Statement on Arterial Stiffness

Jimena Rey-García1,2, Raymond R Townsend3

  • 1Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, Madrid, Spain.

Insights

Large artery stiffness (LAS) is a key cardiovascular risk factor. Guidelines vary on assessing LAS using pulse wave velocity (PWV), but it aids risk prediction and may be improved by certain treatments.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Hypertension Research

Background:

  • Large artery stiffness (LAS) is an independent predictor of cardiovascular disease and mortality.
  • Current hypertension guidelines present differing recommendations on the routine assessment of LAS.
  • Pulse wave velocity (PWV) is recognized as a marker of target organ damage, though its systematic use is debated globally.

Purpose of the Study:

  • To provide an updated review of large artery stiffness (LAS).
  • To discuss the varying guideline positions on assessing LAS via pulse wave velocity (PWV).
  • To summarize recent advances in treatments impacting LAS.

Main Methods:

  • Literature review of current guidelines and recent studies on LAS.
  • Analysis of the role of pulse wave velocity (PWV) in cardiovascular risk stratification.
  • Evaluation of therapeutic interventions affecting LAS, including dietary, pharmacological, and procedural approaches.

Main Results:

  • Guideline recommendations for assessing LAS using PWV differ significantly between European, Asian, and North American authorities.
  • PWV demonstrates value in predicting cardiovascular events and refining risk classification, particularly in intermediate-risk individuals.
  • Interventions like sodium restriction, exercise, statins, mineralocorticoid blockers, and renal denervation show varied effects on LAS.

Conclusions:

  • Despite guideline discrepancies, PWV is a valuable tool for cardiovascular risk assessment.
  • Therapeutic strategies targeting LAS show promise, with ongoing research into their efficacy.
  • Further research is needed to standardize LAS assessment and optimize treatment strategies.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
70
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
86
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
174
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
97
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
64
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63